Novel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung Cancer
Recruiting
Observational Study
Lung Cancer, Non-Small Cell
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- JaxBio Ltd · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This trial is a multicenter, open-label, non-interventional controlled study to identify and characterize epigenetic signatures of lung cancer. The goal of this study is to develop a simple blood test that can detect lung cancer with high sensitivity, and assist in the early diagnosis and management of lung cancer.
In particular, the ability to assist existing methods in cancer diagnostics, predi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Men and women over 18 years old.
* Patients diagnosed with lung cancer before systemic therapy.
* Patients with inconclusive LDCT findings.
* Healthy volunteers.
* Patients with chronic lung diseases (COPD, pulmonary emphysema, acute pneumonia).
Exclusion Criteria:
* Subject…
Contacts